Simpson Thacher & Bartlett LLP

Simpson Thacher & Bartlett LLP remains at the forefront of the DCM field with a proven record in both issuer and underwriter representation. It has a broad mix of investment grade, high-yield, structured finance and mezzanine finance engagements. The firm routinely appears towards the top of the league tables for investment grade and high-yield debt offerings, both for issuers and underwriters. It has a fine reputation for representing first time issuers and has an exceptional blue-chip corporate client base, along with private equity houses and their portfolio companies. In 2023, it advised the underwriters on multiple debt offerings by Pfizer, totalling $31bn. Roxane Reardon is at the forefront of big-ticket transactions, leading many of the firm’s headline deals. Kenneth Wallach is another leading figure, along with Ryan Bekkerus, Hui Lin and Jonathan Ozner. Arthur Robinson is a seasoned and outstanding practitioner. Jessica Asrat and Lia Toback were promoted to the partnership in 2023. All named individuals are based in New York.